OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world. 

Biotechnology

Clinical Trials

Life Sciences

OmniaBio

OmniaBio's headquarters in Hamilton, Canada

This department focuses on identifying and cultivating growth opportunities to drive business partnerships and revenue.

Business Development

This department is responsible for overseeing the production processes and ensuring the efficient operation of manufacturing activities.

Manufacturing Operations

This department is responsible for ensuring the quality and compliance of materials and processes throughout production.

Quality Assurance

This department oversees financial policies and ensures compliance with financial regulations and governance standards.

Finance Governance

This department manages and optimizes the flow of goods, services, and information throughout the supply chain.

Supply Chain Operations

This department ensures adherence to regulations and standards within manufacturing processes.

��

People (3)

Jobs (0)

Other teams

Manufacturing Operations

Quality Assurance

Finance Governance

Supply Chain Operations

Compliance Department

��������

People (3)

Jobs (0)

Other teams

Manufacturing Operations

Quality Assurance

Finance Governance

Supply Chain Operations

Compliance Department

��